<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"><url><loc>https://www.chemistanddruggist.co.uk/news/regulation/regulation-roundup-a-very-busy-month-for-the-gphc-3PCLCNXM2FCBZJW6M45VPNNETQ/</loc><news:news><news:publication><news:name>CnD</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-30T16:17:02.957Z</news:publication_date><news:title><![CDATA[Regulation roundup: A very busy month for the GPhC ]]></news:title></news:news><image:image><image:loc>https://www.chemistanddruggist.co.uk/resizer/putluWC3ewrWg1_nff9iDNEVBRs=/cloudfront-us-east-1.images.arcpublishing.com/norstella/K6G3S3SP3BFTDL4O5DGQOMB63Y.jpg</image:loc><image:caption><![CDATA[A lawyer questioned whether delays in FtP cases could work in pharmacists' favour]]></image:caption></image:image></url><url><loc>https://www.chemistanddruggist.co.uk/news/clinical/access-to-glp-1s-varies-widely-across-scotland-new-report-finds-O7QIL2MKCZCEHB4ZTWG7FHOFXU/</loc><news:news><news:publication><news:name>CnD</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-30T15:28:37.65Z</news:publication_date><news:title><![CDATA[Access to GLP-1s varies ‘widely’ across Scotland, new report finds ]]></news:title></news:news><image:image><image:loc>https://www.chemistanddruggist.co.uk/resizer/bDEh1WEj-2Oq74uhtVsUpZntR_Q=/cloudfront-us-east-1.images.arcpublishing.com/norstella/IPFX5PTEPRPVLGOGRJR6PPXVUM.jpg</image:loc><image:caption><![CDATA[The ABPI found the “greatest variation in access" to medicines among GLP-1s]]></image:caption></image:image></url><url><loc>https://www.chemistanddruggist.co.uk/analysis/partnered-content/omne-trium-perfectum-harnessing-the-power-of-three-in-influenza-45DAKSK4FVDUTPSS6S6GDVWZR4/</loc><news:news><news:publication><news:name>CnD</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-30T11:01:11.865Z</news:publication_date><news:title><![CDATA[Harnessing the power of three in influenza ]]></news:title></news:news><image:image><image:loc>https://www.chemistanddruggist.co.uk/resizer/XharS_js_vj4fnvZNTrtFii8qHI=/cloudfront-us-east-1.images.arcpublishing.com/norstella/DNYICCGMQRAUPH6YT3GKJJ2IWQ.png</image:loc></image:image></url><url><loc>https://www.chemistanddruggist.co.uk/analysis/opinion/from-a-lawyer-can-isps-help-tackle-the-illegal-weight-loss-trade-VNHL4MOU2BENBC4R2NKBKXPQFY/</loc><news:news><news:publication><news:name>CnD</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-30T09:16:32.162Z</news:publication_date><news:title><![CDATA[From a lawyer: Can ISPs help tackle the illegal weight loss trade?]]></news:title></news:news><image:image><image:loc>https://www.chemistanddruggist.co.uk/resizer/YaN9L_OYuLInYhbQ6EQ4InFb1HA=/cloudfront-us-east-1.images.arcpublishing.com/norstella/NWJKITC4SRJZDJXETNZPKCLW4Y.jpg</image:loc><image:caption><![CDATA[Novo Nordisk was granted an injunction that required ISPs to block offending websites]]></image:caption></image:image></url></urlset>